Two Sigma Advisers
GEN

Two Sigma Advisers’s Genesis Healthcare, Inc. GEN Stock Holding History

Two Sigma Advisers’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-29,400
Closed -$14K – 2784
2020
Q4 		$14K Buy
+29,400
New +$14.8K ﹤0.01% 2351
2018
Q3 		– Sell
-18,093
Closed -$41K – 2464
2018
Q2 		$41K Buy
+18,093
New +$35K ﹤0.01% 2314
2015
Q3 		– Sell
-17,293
Closed -$114K – 2061
2015
Q2 		$114K Sell
17,293
-80,100
-82% -$540K ﹤0.01% 1802
2015
Q1 		$693K Buy
+97,393
New +$735K 0.01% 1215

Other funds holding GEN

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Two Sigma Advisers's GEN Position: Q1 2021 in Review

Two Sigma Advisers sold out of Genesis Healthcare, Inc. (GEN) in Q1 2021, closing a stake of 29,400 shares — an estimated $14K sold.

Two Sigma Advisers first reported a position in GEN in Q1 2015 and held it in 4 quarters. The position peaked at $693K in Q1 2015. 8 funds tracked by Wall St. Rank hold GEN as of Q1 2021.

  • Two Sigma Advisers reported no remaining Genesis Healthcare, Inc. position as of Q1 2021 after selling out during the quarter.
  • Two Sigma Advisers sold 29,400 Genesis Healthcare, Inc. shares in Q1 2021, an estimated $14K.
  • Two Sigma Advisers first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 4 quarters.
  • Two Sigma Advisers's Genesis Healthcare, Inc. position peaked at $693K in Q1 2015.
  • 8 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q1 2021.

Based on Two Sigma Advisers's 13F filing for Q1 2021, filed 17 May 2021.